✦ LIBER ✦

The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor

✍ Scribed by Suda, Kenichi; Mizuuchi, Hiroshi; Sato, Katsuaki; Takemoto, Toshiki; Iwasaki, Takuya; Mitsudomi, Tetsuya

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

siRNA mediated the type 1 insulin-like g

✍ Jian Niu; Xiang-nong Li; Haixin Qian; Zeguang Han 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 587 KB

JAK2-related pathway induces acquired er

✍ Daijiro Harada; Nagio Takigawa; Nobuaki Ochi; Takashi Ninomiya; Masayuki Yasugi; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

Insulin-Like Growth Factor-I Receptor Si

✍ Knowlden, J. M.; Hutcheson, I. R.; Barrow, D.; Gee, J. M. W.; Nicholson, R. I. 📂 Article 📅 2005 🏛 Endocrine Society 🌐 English ⚖ 536 KB

Hypoxia induces gefitinib resistance in

✍ Kunihiko Minakata; Fumiyuki Takahashi; Takeshi Nara; Muneaki Hashimoto; Ken Taji 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

Expression of the wild-type insulin-like

✍ Wang, Suna; Thakar, Manjusha; Smolinski, Kara N; Yin, Jing; Zou, Tong-Tong; Kong 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 188 KB

Mechanisms of Acquired Resistance to Epi

✍ Engelman, J. A.; Janne, P. A. 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB